跳至主要内容
临床试验/NCT02619266
NCT02619266Unknown2 期

The Traditional Chinese Medicine Department of Xin Qiao Hospital

Xinqiao Hospital of Chongqing4 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2015年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
160
试验地点
4
主要终点
Appetite Visual Analog Scale

研究概览

简要总结

This trail will be carried out to evaluated the effect and safety of acupuncture for the anorexia in patients with gastrointestinal tract and lung cancers.

详细描述

Acupuncture used for anorexia related to cancer, but there were lack of powerful evidence. The 160 eligibilities will be randomly divided into 3 groups(Acupuncture and Placebo group, Megestrol acetate and Sham Acupuncture group, Placebo and Sham Acupuncture group).The effect will be investigated baseline, the 2,5,8 and 15days. The safety issue will be recorded every section during the acupuncture.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed gastrointestinal tand lung cancers;
  • Age ≥18 years;
  • Appetite score≤ 6 (0= worst appetite), and the symptom lasted 2 weeks at lest at screening;
  • Had a history of weight loss ≥5% within 6 moths;
  • Maintained oral intake;
  • Signed the informed consent.

排除标准

  • Patients with dementia, delirium, intestinal obstruction, pregnancy or lactation;
  • Had uncontrolled symptoms that could impact appetite or caloric intake such as nausea, pain, or depression(The score of the symptoms≤ 3, 0= worst) ;
  • Patients with untreated vitamin B12 deficiency or endocrine abnormalities(thyroid dysfunction and hypoadrenalism);
  • Patients on melatonin supplements or medications with potential appetite-stimulating activity(Chinese herb,thalidomide)
  • Less than one week before the screening or there will be a surgery ,radiotherapy and chemotherapy the acupuncture;
  • Lifetime expected less than 3 months.

研究组 & 干预措施

Acupuncture+Placebo

Experimental

Acupuncture once daily for 7 days and Placebo tablet by mouth, twice a day for 7 days.

干预措施: Acupuncture (Other)

Acupuncture+Placebo

Experimental

Acupuncture once daily for 7 days and Placebo tablet by mouth, twice a day for 7 days.

干预措施: Placebo(Megestrol Acetate) (Drug)

Megestrol Acetate+Sham acupuncture

Active Comparator

Megestrol Acetate tablet 160mg by mouth, twice a day for 7 days and Sham Acupuncture once a day for 7 days .

干预措施: Sham Acupuncture (Other)

Megestrol Acetate+Sham acupuncture

Active Comparator

Megestrol Acetate tablet 160mg by mouth, twice a day for 7 days and Sham Acupuncture once a day for 7 days .

干预措施: Megestrol Acetate (Drug)

Placebo+Sham acupuncture

Placebo Comparator

Placebo tablet by mouth, twice a day for 7 days and Sham Acupuncture once a day for 7 days .

干预措施: Sham Acupuncture (Other)

Placebo+Sham acupuncture

Placebo Comparator

Placebo tablet by mouth, twice a day for 7 days and Sham Acupuncture once a day for 7 days .

干预措施: Placebo(Megestrol Acetate) (Drug)

结局指标

主要结局

Appetite Visual Analog Scale

时间窗: Baseline, the days 8 and 15.

The assessment will be done thirty minutes before meals. The participators should record the score of their appetite (0 to 100 mm) the higher scores reflect better symptom control.

次要结局

  • Council of Nutrition appetite questionnaire (CNAQ)(Baseline, the days 8 and 15.)
  • Caloric intake(Baseline, the days 8 and 15.)
  • Functional Assessment of Anorexia/Cachexia Therapy(Baseline, the days 8 and 15.)
  • Nutritional status(Baseline, the days 8 and 15.)

研究者

发起方
Xinqiao Hospital of Chongqing
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chaoting Zhao

Vice Director, Clinical Reseach

Xinqiao Hospital of Chongqing

研究点 (4)

Loading locations...

相似试验

The Safety and Effect Study of Acupuncture for... | 临床试验